Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by Kanatainvestoron Oct 20, 2023 1:41pm
128 Views
Post# 35693397

23 days left for the definitive buyout agreement to be signe

23 days left for the definitive buyout agreement to be signeHere is an interesting piece of information, when NBLY announced the signing of the go-private deal with PCP, the yield on the Canadian 10 year government bond was 4.15% (https://www.barrons.com/market-data/bonds/tmbmkca-10y?countrycode=bx) today, the yield stand at 4.08%, which means the outlook for long term interest rates has improved since the deal was announced. Likewise for the 5 year, which declined from 4.34% the day the deal was announced to 4.25% today. Meanwhile the 2 year has hardly changed trading at 4.9% on October 3rd and 4.91% today. Thus, if anything the outlook for interest rates longer term is more constructive, this is a positive development for a partially debt funded deal.

The point of the above is that nothing has changed from a macro standpoint to render the deal less favourable. And yet the discount to the offer price has doubled from 7% to 15% today within two weeks, on low volume, and no major piece of news.  The funny thing on August 1st after the strong Q2 earning report NBLY traded at a higher price than today’s price on strong volume (closing that day at $17.68). And yet, with $20.5 signed letter of intent from a credible buyer, the stock is trading at a lower price.

Next week, NBLY will likely report another strong quarter as the initiatives introduced by the new management team start to show more meaningfully in the results. And shortly after that, we are likely going to see a news release stating that NBLY has signed a definitive buyout agreement with PCP. The market has missed the possibility of the buyout (something I highlighted days before the deal was announced) and now yet again those selling are missing what’s right before their eyes.


<< Previous
Bullboard Posts
Next >>